730 research outputs found
Mechanisms of cognitive impairment in epilepsy
Cognitive impairment and dementia are increasingly reported as people with epilepsy grow older, with major impact on quality of life. The underlying mechanisms of cognitive dysfunction, however, and the magnitude of associated dementia risk in epilepsy remains unclear. This thesis will explore how cardiovascular risk factors and hippocampal dysfunction are two important mechanistic links between epilepsy and dementia.
Using data from a large population-based cohort, the studies in this thesis demonstrate that cardiovascular risk factors are closely related to impairment of executive function. One finding highlighted a continuous dose-response relation of cognition with blood pressure, even in non-hypertensive individuals. The relationship between cardiovascular risk and cognition was mediated through changes in both frontoparietal white and grey matter structural networks. In the same cohort, people with epilepsy and a high cardiovascular risk were over 13 times more likely to develop dementia compared to healthy controls with low cardiovascular risk. People with epilepsy had a greater risk of developing dementia even compared with individuals with a history of stroke, with associated changes to hippocampal volume.
To examine specific hippocampal-related cognitive mechanisms that may underlie memory difficulties in epilepsy, I examined two processes believed to be central to encoding and retrieval in the hippocampus: pattern separation and pattern completion. I devised a novel computer-based behavioural paradigm called the Memory Pinhole Task to distinguish them. Impairment of these two cognitive operations have been identified in ageing and other conditions such as Alzheimerβs disease. Compared to healthy controls, pattern separation deficits were observed in people with epilepsy while reduced pattern completion was seen in healthy older individuals. I then mapped these findings from the Memory Pinhole task onto potential brain mechanisms through computational modelling using a neural network.
The work in this thesis describes how modifiable cardiovascular risk factors significantly contribute to cognitive ageing and dementia risk in healthy individuals and people with epilepsy. This has important implications for personal health practices and clinical guidelines, especially in people with epilepsy as there is no current guidance to mitigate dementia risk. Further, I describe a framework for testing encoding and retrieval of information into memory which may allow us to better understand difficulties seen in both health and disease
Extreme Learning Machine-Assisted Solution of Biharmonic Equations via Its Coupled Schemes
Obtaining the solutions of partial differential equations based on various
machine learning methods has drawn more and more attention in the fields of
scientific computation and engineering applications. In this work, we first
propose a coupled Extreme Learning Machine (called CELM) method incorporated
with the physical laws to solve a class of fourth-order biharmonic equations by
reformulating it into two well-posed Poisson problems. In addition, some
activation functions including tangent, gauss, sine, and trigonometric
(sin+cos) functions are introduced to assess our CELM method. Notably, the sine
and trigonometric functions demonstrate a remarkable ability to effectively
minimize the approximation error of the CELM model. In the end, several
numerical experiments are performed to study the initializing approaches for
both the weights and biases of the hidden units in our CELM model and explore
the required number of hidden units. Numerical results show the proposed CELM
algorithm is high-precision and efficient to address the biharmonic equation in
both regular and irregular domains
Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors
Importance: Epilepsy has been associated with cognitive impairment and potentially dementia in older individuals. However, the extent to which epilepsy may increase dementia risk, how this compares with other neurological conditions, and how modifiable cardiovascular risk factors may affect this risk remain unclear.
Objective: To compare the differential risks of subsequent dementia for focal epilepsy compared with stroke and migraine as well as healthy controls, stratified by cardiovascular risk.
Design, Setting, and Participants: This cross-sectional study is based on data from the UK Biobank, a population-based cohort of more than 500β―000 participants aged 38 to 72 years who underwent physiological measurements and cognitive testing and provided biological samples at 1 of 22 centers across the United Kingdom. Participants were eligible for this study if they were without dementia at baseline and had clinical data pertaining to a history of focal epilepsy, stroke, or migraine. The baseline assessment was performed from 2006 to 2010, and participants were followed up until 2021.
Exposures: Mutually exclusive groups of participants with epilepsy, stroke, and migraine at baseline assessment and controls (who had none of these conditions). Individuals were divided into low, moderate, or high cardiovascular risk groups based on factors that included waist to hip ratio, history of hypertension, hypercholesterolemia, diabetes, and smoking pack-years.
Main Outcomes and Measures: Incident all-cause dementia; measures of executive function; and brain total hippocampal, gray matter, and white matter hyperintensity volumes.
Results: Of 495β―149 participants (225β―481 [45.5%] men; mean [SD] age, 57.5 [8.1] years), 3864 had a diagnosis of focal epilepsy only, 6397 had a history of stroke only, and 14β―518 had migraine only. Executive function was comparable between participants with epilepsy and stroke and worse than the control and migraine group. Focal epilepsy was associated with a higher risk of developing dementia (hazard ratio [HR], 4.02; 95% CI, 3.45 to 4.68; Pβ<β.001), compared with stroke (HR, 2.56; 95% CI, 2.28 to 2.87; Pβ<β.001), or migraine (HR, 1.02; 95% CI, 0.85 to 1.21; Pβ=β.94). Participants with focal epilepsy and high cardiovascular risk were more than 13 times more likely to develop dementia (HR, 13.66; 95% CI, 10.61 to 17.60; Pβ<β.001) compared with controls with low cardiovascular risk. The imaging subsample included 42β―353 participants. Focal epilepsy was associated with lower hippocampal volume (mean difference, β0.17; 95% CI, β0.02 to β0.32; tβ=ββ2.18; Pβ=β.03) and lower total gray matter volume (mean difference, β0.33; 95% CI, β0.18 to β0.48; tβ=ββ4.29; Pβ<β.001) compared with controls. There was no significant difference in white matter hyperintensity volume (mean difference, 0.10; 95% CI, β0.07 to 0.26; tβ=β1.14; Pβ=β.26).
Conclusions and Relevance: In this study, focal epilepsy was associated with a significant risk of developing dementia, to a greater extent than stroke, which was magnified substantially in individuals with high cardiovascular risk. Further findings suggest that targeting modifiable cardiovascular risk factors may be an effective intervention to reduce dementia risk in individuals with epilepsy
Artificial intelligence for dementia prevention
INTRODUCTION:
A wide range of modifiable risk factors for dementia have been identified. Considerable debate remains about these risk factors, possible interactions between them or with genetic risk, and causality, and how they can help in clinical trial recruitment and drug development. Artificial intelligence (AI) and machine learning (ML) may refine understanding.//
METHODS:
ML approaches are being developed in dementia prevention. We discuss exemplar uses and evaluate the current applications and limitations in the dementia prevention field.//
RESULTS:
Risk-profiling tools may help identify high-risk populations for clinical trials; however, their performance needs improvement. New risk-profiling and trial-recruitment tools underpinned by ML models may be effective in reducing costs and improving future trials. ML can inform drug-repurposing efforts and prioritization of disease-modifying therapeutics.//
DISCUSSION:
ML is not yet widely used but has considerable potential to enhance precision in dementia prevention
Identification of Genes with Allelic Imbalance on 6p Associated with Nasopharyngeal Carcinoma in Southern Chinese
Nasopharyngeal carcinoma (NPC) is a malignancy of epithelial origin. The etiology of NPC is complex and includes multiple genetic and environmental factors. We employed case-control analysis to study the association of chromosome 6p regions with NPC. In total, 360 subjects and 360 healthy controls were included, and 233 single nucleotide polymorphisms (SNPs) on 6p were examined. Significant single-marker associations were found for SNPs rs2267633 (pβ=β4.49Γ10β5), rs2076483 (most significant, pβ=β3.36Γ10β5), and rs29230 (pβ=β1.43Γ10β4). The highly associated genes were the gamma-amino butyric acid B receptor 1 (GABBR1), human leukocyte antigen (HLA-A), and HLA complex group 9 (HCG9). Haplotypic associations were found for haplotypes AAA (located within GABBR1, p-value β=β6.46Γ10β5) and TT (located within HLA-A, pβ=β0.0014). Further investigation of the homozygous genotype frequencies between cases and controls suggested that micro-deletion regions occur in GABBR1 and neural precursor cell expressed developmentally down-regulated 9 (NEDD9). Quantitative real-time polymerase chain reaction (qPCR) using 11 pairs of NPC biopsy samples confirmed the significant decline in GABBR1 and NEDD9 mRNA expression in the cancer tissues compared to the adjacent non-tumor tissue (p<0.05). Our study demonstrates that multiple chromosome 6p susceptibility loci contribute to the risk of NPC, possibly though GABBR1 and NEDD9 loss of function
Impact of the COVID-19 pandemic on people with epilepsy: findings from the Brazilian arm of the COV-E study
The COVID-19 pandemic has had an unprecedented impact on people and healthcare services. The disruption to chronic illnesses, such as epilepsy, may relate to several factors ranging from direct infection to secondary effects from healthcare reorganization and social distancing measures.
Objectives:
As part of the COVID-19 and Epilepsy (COV-E) global study, we ascertained the effects of COVID-19 on people with epilepsy in Brazil, based on their perspectives and their perspectives those of those of their caregivers. We also evaluated the impact of COVID-19 on the care delivered to people with epilepsy by healthcare workers.
Methods:
We designed separate online surveys for people with epilepsy and their caregivers. A further survey for healthcare workers contained additional assessments of changes to working patterns, productivity, and concerns for those with epilepsy under their care. The Brazilian arm of COV-E initially collected data from April to November 2020 during the country's first wave. We also examined national data to identify the Brazilian states with the highest COVID-19 incidence and related mortality. Lastly, we applied this geographic grouping to our data to explore whether local disease burden played a direct role in difficulties faced by people with epilepsy.
Results:
Two hundred and forty-one people returned the survey, 20% were individuals with epilepsy (n = 48); 22% were caregivers (n = 53) and 58% were healthcare workers (n = 140). Just under half (43%) of people with epilepsy reported health changes during the pandemic, including worsening seizure control, with specific issues related to stress and impaired mental health. Of respondents prescribed antiseizure medication, 11% reported difficulty taking medication on time due to problems acquiring prescriptions and delayed or cancelled medical appointments. Only a small proportion of respondents reported discussing significant epilepsy-related risks in the previous 12 months. Analysis of national COVID-19 data showed a higher disease burden in the states of Sao Paulo and Rio de Janeiro compared to Brazil as a whole. There were, however, no geographic differences observed in survey responses despite variability in the incidence of COVID-19.
Conclusion:
Our findings suggest that Brazilians with epilepsy have been adversely affected by COVID-19 by factors beyond infection or mortality. Mental health issues and the importance of optimal communication are critical during these difficult times. Healthcare services need to find nuanced approaches and learn from shared international experiences to provide optimal care for people with epilepsy as the direct burden of COVID-19 improves in some countries. In contrast, others face resurgent waves of the pandemic
- β¦